Abstract
AbstractOur previous studies revealed a novel link between gemcitabine (GEM) chemotherapy and elevated glutamine-fructose-6-phosphate transaminase 2 (GFPT2) expression in pancreatic cancer (PaCa) cells. GFPT2 is a rate-limiting enzyme in the hexosamine biosynthesis pathway (HBP). HBP can enhance metastatic potential by regulating epithelial-mesenchymal transition (EMT). The aim of this study was to further evaluate the effect of chemotherapy-induced GFPT2 expression on metastatic potential. GFPT2 expression was evaluated in a mouse xenograft model following GEM exposure and in clinical specimens of patients after chemotherapy using immunohistochemical analysis. The roles of GFPT2 in HBP activation, downstream pathways, and cellular functions in PaCa cells with regulated GFPT2 expression were investigated. GEM exposure increased GFPT2 expression in tumors resected from a mouse xenograft model and in patients treated with neoadjuvant chemotherapy (NAC). GFPT2 expression was correlated with post-operative liver metastasis after NAC. Its expression activated the HBP, promoting migration and invasion. Treatment with HBP inhibitors reversed these effects. Additionally, GFPT2 upregulated ZEB1 and vimentin expression and downregulated E-cadherin expression. GEM induction upregulated GFPT2 expression. Elevated GFPT2 levels promoted invasion by activating the HBP, suggesting the potential role of this mechanism in promoting chemotherapy-induced metastasis.
Funder
Grant-in-Aid for Scientific Research
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. International Agency for Research on Cancer (2020). Data visualization tools for exploring the global cancer burden in 2020. https://gco.iarc.fr/today. Accessed 1st. March 2022
2. Ushio J, Kanno A, Ikeda E, Ando K, Nagai H, Miwata T, Kawasaki Y, Tada Y, Yokoyama K, Numao N, Tamada K (2021) Pancreatic ductal adenocarcinoma: epidemiology and risk factors. Diagnostics 11:562. https://doi.org/10.3390/diagnostics11030562
3. Saad AM, Turk T, Al-Husseini MJ, Abdel-Rahman O (2018) Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study. BMC Cancer 18:688. https://doi.org/10.1186/s12885-018-4610-4
4. Cancer registry and statistics. https://ganjoho.jp/reg_stat/statistics/stat/summary.html. Accessed 10 Apr 2022. Cancer Information Service, National Cancer Center, Japan (Ministry of Health, Labor and Welfare National cancer registry)
5. National Comprehensive Cancer Network NCCN practice guidelines for pancreatic cancer, version 1 (2024). http://nccn.org/professionals/physician_gls/pdf/pancreatic.pdf. Accessed 23 Dec, 2023